Tudor Investment Corp ET AL lowered its position in Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report) by 47.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,873 shares of the company’s stock after selling 18,682 shares during the quarter. Tudor Investment Corp ET AL owned approximately 0.06% of Crescent Capital BDC worth $401,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of the company. Franklin Resources Inc. boosted its stake in Crescent Capital BDC by 12.8% during the 4th quarter. Franklin Resources Inc. now owns 289,131 shares of the company’s stock worth $5,557,000 after purchasing an additional 32,852 shares during the period. Condor Capital Management raised its holdings in shares of Crescent Capital BDC by 4.7% in the fourth quarter. Condor Capital Management now owns 284,055 shares of the company’s stock valued at $5,460,000 after buying an additional 12,852 shares during the last quarter. Wells Fargo & Company MN boosted its stake in shares of Crescent Capital BDC by 0.5% during the fourth quarter. Wells Fargo & Company MN now owns 253,182 shares of the company’s stock worth $4,866,000 after buying an additional 1,210 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Crescent Capital BDC during the fourth quarter worth about $3,750,000. Finally, Denali Advisors LLC increased its position in Crescent Capital BDC by 0.5% in the 4th quarter. Denali Advisors LLC now owns 183,783 shares of the company’s stock valued at $3,532,000 after acquiring an additional 855 shares during the period. 49.46% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several brokerages have weighed in on CCAP. Keefe, Bruyette & Woods lowered their target price on Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating on the stock in a research note on Tuesday, April 8th. Wells Fargo & Company lowered their price objective on shares of Crescent Capital BDC from $18.00 to $16.00 and set an “equal weight” rating on the stock in a research report on Monday, April 28th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Crescent Capital BDC currently has an average rating of “Moderate Buy” and a consensus price target of $18.50.
Crescent Capital BDC Stock Up 0.6 %
Crescent Capital BDC stock opened at $16.05 on Friday. The stock’s 50 day moving average price is $16.29 and its 200 day moving average price is $18.15. Crescent Capital BDC, Inc. has a 1-year low of $13.54 and a 1-year high of $20.19. The company has a market cap of $594.81 million, a PE ratio of 8.07 and a beta of 0.63. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The company had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. On average, sell-side analysts predict that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.
Crescent Capital BDC Announces Dividend
The business also recently announced a dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be issued a $0.05 dividend. The ex-dividend date of this dividend is Friday, May 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 84.42%.
Crescent Capital BDC Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- How to Invest in Insurance Companies: A GuideÂ
- Google Is Betting Big on Nuclear Reactors—Should You?
- A Deeper Look at Bid-Ask Spreads
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Differences Between Momentum Investing and Long Term Investing
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.